Delivering on the promise: HPV vaccines and cervical cancer.
about
Papillomavirus genome structure, expression, and post-transcriptional regulationVirus maturation: dynamics and mechanism of a stabilizing structural transition that leads to infectivity.Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisEstablishment of human papillomavirus infection requires cell cycle progressionIn silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.Potential anti-HPV and related cancer agents from marine resources: an overview.Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cellsVaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 yearsHuman alpha-defensins block papillomavirus infectionVaccines: past, present and future.Reducing the health burden of HPV infection through vaccination.Next Generation Cancer Protection: The Bivalent HPV Vaccine for FemalesCytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.Genital warts: a comprehensive reviewVirology. Epstein-Barr virus turns 50.Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma.Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.Mothers' human papilloma virus knowledge and willingness to vaccinate their adolescent daughters in Lagos, NigeriaListeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunizationIdentification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.Monitoring of human papillomavirus vaccination.Resveratrol as an anti-cancer agent: A review.High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.Therapeutic vaccines for high-risk HPV-associated diseases.Vaccines for cervical cancer.Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches.
P2860
Q22255483-EC8F4829-4A07-4C2A-86EE-950680269CAEQ27472833-3320B58B-8B10-4B5B-AD63-7548F5B62B44Q28077209-FDA939D1-5035-4682-ADFE-7DDA57E0C49FQ28474811-E518547C-2BEC-477C-88F0-305842D0771AQ30661799-DE5CAF24-0E21-4929-A196-558AB5A2EFBFQ33575647-C3CD0485-708C-490A-A521-6AD68DA13F78Q33925336-A151C4FA-957D-4F34-8527-A5924266D771Q34014798-65635EC7-80CC-4C87-90C5-984A051B6543Q34334899-DEC34ABA-ABBE-4EFE-8FFC-8D6DBE2702BDQ34409178-602F87B5-95D4-465E-B5D1-86EEA2933A4FQ34863221-0E1A05B0-1F42-4020-9565-30C6924B414AQ35550810-6123CFCC-9F22-4903-8F16-7AC6FB2DF191Q35784867-F59815EC-4EB3-4FE5-9F63-0C1891FA5D94Q36077814-D140FFA4-B5E7-4E7F-8C73-92CFDC3DF1E0Q36088975-E848BADF-7E46-4F70-8A0D-89C415A47458Q36366466-F846CA26-8413-4D2C-BC27-B4B2C631BBD2Q36426605-8F11D241-50D6-4047-B33C-8595E4C878C9Q36793117-55DF9B23-49BD-498B-827C-6176B2EB80CAQ36813522-BF7DF23F-9745-4977-85CC-F3CE8B31A09AQ37014077-CE735B32-0870-42EC-96D6-421501612710Q37391175-8E0BE778-9A1D-4339-8563-3ECDD559470EQ37419555-69529AF5-EC8A-4211-A516-3F5CADE95BF6Q37808256-7141E30B-DBA7-485F-8EFC-D5EA3ECE9022Q39045911-5DD45999-E160-4E1A-A05D-C802B3071E3AQ45420696-68211A8A-2B38-4420-9152-C6B60DB9FD5CQ47255618-DD3BC036-B2D4-4608-A682-131063FBE3FAQ47604101-609E112F-CA45-4040-AE60-DBA2877D7B69Q55007219-A9F332EC-EE68-40D6-8DBF-58E454567F89
P2860
Delivering on the promise: HPV vaccines and cervical cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Delivering on the promise: HPV vaccines and cervical cancer.
@ast
Delivering on the promise: HPV vaccines and cervical cancer.
@en
type
label
Delivering on the promise: HPV vaccines and cervical cancer.
@ast
Delivering on the promise: HPV vaccines and cervical cancer.
@en
prefLabel
Delivering on the promise: HPV vaccines and cervical cancer.
@ast
Delivering on the promise: HPV vaccines and cervical cancer.
@en
P2860
P356
P1476
Delivering on the promise: HPV vaccines and cervical cancer.
@en
P2093
John T Schiller
Philip Davies
P2860
P2888
P304
P356
10.1038/NRMICRO867
P407
P577
2004-04-01T00:00:00Z
P5875
P6179
1036966892